StonvexLoading…
StonvexStonvexStonvexCore line items from VIVK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $19.46M | $104.42M | $83.42M | $66.44M |
Operating Income | $-2.43M | $-63.83M | $-22.25M | $-13.22M |
Net Income | $-4.58M | $-110.24M | $-54.35M | $-20.06M |
EPS (Diluted) | $-2.32 | $-318.01 | $-1.69 | $-0.52 |
Total Assets | $111.79M | $113.49M | $160.13M | $244.54M |
Total Liabilities | $78.15M | $76.30M | $96.09M | $146.50M |
Cash & Equivalents | $4.46K | $265.02K | $299.64K | $413.75K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.85M | 2.01M | 61.43M | 48.83M |